Potentiation of isoniazid activity against Mycobacterium tuberculosis by melatonin

Antimicrob Agents Chemother. 1999 Apr;43(4):975-7. doi: 10.1128/AAC.43.4.975.

Abstract

The limited number of effective antituberculosis drugs available necessitates optimizing current treatments. We show that melatonin, which is synthesized in the pineal gland, can cause at least a threefold increase in the efficacy of isoniazid. This suggests that tuberculosis chemotherapy can be improved by innate molecules such as melatonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology*
  • Antitubercular Agents / pharmacology*
  • Drug Resistance, Multiple
  • Drug Synergism
  • Humans
  • Isoniazid / pharmacology*
  • Melatonin / pharmacology*
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / cytology
  • Mycobacterium tuberculosis / drug effects*

Substances

  • Antioxidants
  • Antitubercular Agents
  • Melatonin
  • Isoniazid